Vestal Point Capital, LP Biomarin Pharmaceutical Inc Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 860,000 shares of BMRN stock, worth $50.9 Million. This represents 3.35% of its overall portfolio holdings.
Number of Shares
860,000
Previous 400,000
115.0%
Holding current value
$50.9 Million
Previous $28.1 Billion
101.05%
% of portfolio
3.35%
Previous 2.13%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.35 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.15 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.08 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$873 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$769 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...